RED: TA278 for the treatment of severe persistent allergic asthma. NHS England drug. To be used in line with NHS England commissioning intentions.
RED: TA339 for previously treated chronic spontaneous urticaria (Decision date - July 2015). ICB commissioned.
DNP: TA678 - Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (Decision date - March 2021)